TY - JOUR
T1 - The Prospective Registry Evaluating Myocardial Infarction
T2 - Events and Recovery (PREMIER) - Evaluating the impact of myocardial infarction on patient outcomes
AU - Spertus, John A.
AU - Peterson, Eric
AU - Rumsfeld, John S.
AU - Jones, Philip G.
AU - Decker, Carole
AU - Krumholz, Harlan
N1 - Funding Information:
This study was principally supported by CV Therapeutics, Inc, Palo Alto, CA, and R-01 HS11282-01 from the Agency for Healthcare Research and Quality, Rockville, MD. This study was also supported by a Veterans Affairs Health Services Research Advanced Research Career Development Award (ARCD-98-341-2) (Dr Rumsfeld), Washington, DC.
PY - 2006/3
Y1 - 2006/3
N2 - Background: More information on the longitudinal care and outcomes of patients after myocardial infarction (MI) is needed to further improve the quality of MI care. The PREMIER study was designed to meet this need. Methods: Patients with MI were prospectively screened and enrolled from 19 US centers between January 1, 2003, and June 28, 2004. Consenting patients had detailed chart abstractions of their medical history and processes of inpatient care, supplemented with a detailed, patient-centered interview. Centralized follow-up at 1, 6, and 12 months is being conducted to quantify patients' postdischarge care and outcomes, with a focus on their health status (symptoms, function, and quality of life). In 2003, detailed chart abstractions, devoid of all personal health information, were collected for patients eligible but not enrolled in PREMIER. Results: Of 10 911 patients screened, 3953 were eligible and 2498 enrolled into PREMIER. Few clinically significant differences between the total MI population and those enrolled into PREMIER were observed. Adherence to accepted processes of quality care, such as aspirin and β-blockers on admission (96% and 91%) or discharge (96% and 93%), was high. One-month follow-up rates were high, with only 9% of patients being lost to follow-up. Conclusion: PREMIER is a novel registry with detailed insights into patients' sociodemographic, clinical, and health status characteristics, as well as detailed monitoring of their inpatient and outpatient processes of care. Ultimately, PREMIER will describe patients' health status outcomes and identify determinants of these outcomes as an important step toward improving MI care.
AB - Background: More information on the longitudinal care and outcomes of patients after myocardial infarction (MI) is needed to further improve the quality of MI care. The PREMIER study was designed to meet this need. Methods: Patients with MI were prospectively screened and enrolled from 19 US centers between January 1, 2003, and June 28, 2004. Consenting patients had detailed chart abstractions of their medical history and processes of inpatient care, supplemented with a detailed, patient-centered interview. Centralized follow-up at 1, 6, and 12 months is being conducted to quantify patients' postdischarge care and outcomes, with a focus on their health status (symptoms, function, and quality of life). In 2003, detailed chart abstractions, devoid of all personal health information, were collected for patients eligible but not enrolled in PREMIER. Results: Of 10 911 patients screened, 3953 were eligible and 2498 enrolled into PREMIER. Few clinically significant differences between the total MI population and those enrolled into PREMIER were observed. Adherence to accepted processes of quality care, such as aspirin and β-blockers on admission (96% and 91%) or discharge (96% and 93%), was high. One-month follow-up rates were high, with only 9% of patients being lost to follow-up. Conclusion: PREMIER is a novel registry with detailed insights into patients' sociodemographic, clinical, and health status characteristics, as well as detailed monitoring of their inpatient and outpatient processes of care. Ultimately, PREMIER will describe patients' health status outcomes and identify determinants of these outcomes as an important step toward improving MI care.
UR - http://www.scopus.com/inward/record.url?scp=33344456588&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33344456588&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2005.05.026
DO - 10.1016/j.ahj.2005.05.026
M3 - Article
C2 - 16504619
AN - SCOPUS:33344456588
SN - 0002-8703
VL - 151
SP - 589
EP - 597
JO - American heart journal
JF - American heart journal
IS - 3
ER -